中航西飛(000768.SZ):中航證券聚富優選2號擬增持3750萬元-7500萬元公司股份 已增持146.77萬股
格隆匯6月9日丨中航西飛(000768.SZ)公佈,公司於2022年6月9日收到公司控股股東一致行動人中航證券有限公司出具的《關於聚富優選2號資管計劃增持中航西飛股票的吿知函》,基於對公司未來持續穩定健康發展的信心,中航證券聚富優選2號於2022年6月9日通過深圳證券交易所集中競價交易系統增持中航西飛股份146.77萬股,佔公司總股本的0.0530%,增持金額約為人民幣4084.99萬元。
中航證券聚富優選2號自2022年6月9日起未來6個月內將繼續增持公司股份,累計增持金額不低於3750萬元且不超過7500萬元(含2022年6月9日增持金額)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.